About Krishgen
Data last updated:
Krishgen is a company based in Mumbai (India) founded in 2003. It operates as a B2B. Krishgen offers products and services including KRIBIOLISA ELISA, Antibody Drug Conjugate ELISA, Host Cell Protein ELISA, and Human Biomarker ELISA. Krishgen operates in a competitive market with competitors including Abcam, Stem Cell Technologies, Meridian Bioscience, Teknova and Sangon Biotech, among others.
- Headquarter Mumbai, India
- SectorsHealthcare
- EmailLocked
- Website krishgen.com
- Social X Facebook
- Legal Name Krishgen Pudgala Llp
- Date of Incorporation 06 Oct, 2017
- Jurisdiction Mumbai, Maharashtra, India
Associated legal entities of Krishgen
Krishgen operates through Krishgen Pudgala Llp (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Report |
|---|---|---|---|---|---|---|---|
| Krishgen Pudgala Llp CIN AAK-7825 | Active | 06 Oct 2017 | Mumbai, Maharashtra | ₹0.0 Cr | – | 2 | Buy report |
Board of directors of Krishgen Pudgala Llp (Krishgen)
Krishgen Pudgala Llp is the primary company behind Krishgen. The board of Krishgen Pudgala Llp currently have 2 directors; the longest-serving is Kalpesh Ramanlal Jain, appointed in 2017.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Kalpesh Ramanlal Jain DIN 01872114 | Designated Partner | 06 Oct 2017 | 9 yrs | Krishgen Pudgala Llp |
| Neelam Jain Kalpesh DIN 07364636 | Designated Partner | 06 Oct 2017 | 9 yrs | Krishgen Pudgala Llp |
Products & Services of Krishgen
Krishgen offers a comprehensive portfolio of products and services, including KRIBIOLISA ELISA, Antibody Drug Conjugate ELISA, Host Cell Protein ELISA, and Human Biomarker ELISA.
Provides assays for detecting biomarkers in research and development
Monitors antibody drugs in pharmaceutical applications
Detects contamination in biologics manufacturing processes
Analyzes human health markers for clinical research
Financials of Krishgen
Figures of Krishgen Pudgala Llp, the primary company behind Krishgen, for FY 2023. Revenue was ₹0.02 Cr (+118% year on year).
- ₹0.02 CrRevenue · FY 2023 · +118% YoY
Balance sheet, profit and loss, cash flow and ratios of Krishgen Pudgala Llp are on its company page.
Buy the company report of Krishgen Pudgala LlpDetailed financial statements for Krishgen
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Krishgen
Krishgen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Stem Cell Technologies, Meridian Bioscience, Teknova and Sangon Biotech, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| abcam.com | 1998 | Cambridge, United Kingdom | $78.8M | 405 | Biological reagents and antibodies are developed for life science research. | |
| stemcell.com | 1993 | Vancouver, Canada | $11.9M | 129 | Developer of cell culture media and ancillary reagents for life science research | |
| meridianbioscience.com | 1976 | Ohio, United States | – | – | Molecular diagnostic device and kits | |
| teknova.com | 1996 | Hollister, United States | – | 290 | Molecular biology reagents and kits are supplied for research applications. | |
| sangon.com | 2003 | Shanghai, China | $300.0M | – | Research services, reagents, and kits for biotech applications are provided. | |
| caymanchem.com | 1980 | Ann Arbor, United States | – | 309 | Bioreagents and assay kits are developed, with preclinical services provided. | |
| bbisolutions.com | 1986 | Crumlin, United Kingdom | – | 301 | Kits and reagents are developed for life science research applications. | |
| biochain.com | 1994 | Hayward, United States | $7.3M | 24 | Provider of products and services for clinical diagnosis, genomics, and proteomics | |
| pl-bioscience.com | 2015 | Aachen, Germany | $13.0M | 13 | Cell culture solutions for stem cell expansion are provided. |
Detailed competitors of Krishgen
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Krishgen
Complete news archive for Krishgen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Krishgen
Krishgen was founded in 2003.
Krishgen is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Krishgen Biosystems specializes in producing high-quality ELISA kits for therapeutic discovery, vaccine development, and biomarker analysis. They operate from Cerritos, California, USA, offering validated assays for sectors like oncology and inflammation. The company serves researchers and companies worldwide through distribution networks, ensuring accurate results with rigorous quality standards and technical support.
Krishgen's top competitors include Abcam, Meridian Bioscience and Stem Cell Technologies.
Krishgen offers KRIBIOLISA ELISA, Antibody Drug Conjugate ELISA, Host Cell Protein ELISA, and Human Biomarker ELISA.
Krishgen operates through Krishgen Pudgala Llp.
The legal entities of Krishgen currently have 2 directors, including Kalpesh Ramanlal Jain, Neelam Jain Kalpesh.